Factors contributing to discrepancies in population monitoring studies

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 467-478

  Au, William W ^a   Cajas Salazar, Nohelia ^a   Salama, Salama ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Biomarker; Chromosome aberration; Health risk assessment; hprt gene mutation; Population monitoring

Indexed keywords

CYTOCHROME P450; ENVIRONMENTAL MUTAGEN; GLUTATHIONE TRANSFERASE;

CHROMOSOME ABERRATION; CIGARETTE SMOKING; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GENOTOXICITY; HEALTH HAZARD; HUMAN; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0032565548     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00058-X     Document Type: Article

References (85)

1. [1] Dellarco, V., Current trends in health risk assessment strategies for environmental agents, Presented in the Conference on Cancer and Genetic Risk Assessment: Low Dose-Effect Studies, Heidelbery, Germany, September 4-6, 1997.
2. [2] B.L. Johnson, Nature, extent, and impact of Superfund hazardous waste sites, Chemosphere 31 (1) (1995) 2415-2418.
3. [3] National Research Council, Environmental Epidemiology: Public Health and Hazardous Wastes, State and Federal Context for Environmental Epidemiology of Hazardous Wastes, National Academy Press, Washington, DC, 1991, pp. 60-100.
4. [4] A.V. Carrano, A.T. Natarajan, Considerations for population monitoring using cytogenetic techniques, Mutat. Res. 204 (1988) 379-406.
5. [5] E.B. Whorton, D.E. Bee, D.J. Kilian, Variations in the proportion of abnormal cells and required sample sizes for human cytogenetic studies, Mutat. Res. 64 (1979) 79-86.
6. [6] E.B. Whorton, Some experimental design and analysis considerations for cytogenetics studies, Environ. Mutagen. 7 (1985) 9-15, (suppl. 4).
7. [7] W.W. Au, R.G. Lane, M.S. Legator, E.B. Whorton Jr., G.S. Wilkinson, G.J. Gabehart, Biomarker monitoring of a population residing near uranium mining activities, Environ. Health Perspect. 103 (1995) 466-470.
8. [8] G. Obe, W.D. Heler, H.J. Vogt, Mutagenic activity of cigarette smoke, in: G. Obe (Ed.), Mutation in Man, Springer-Verlag, Berlin, Germany, 1984, pp. 223-246.
9. [9] Vijayalaxmi, H.J. Evans, In vivo and in vitro effects of cigarette smoke on chromosomal damage and sister-chromatid exchange in human peripheral blood lymphocytes, Mutation Res. 92 (1982) 321-332.
10. [10] S.M. Galloway, P.K. Berry, W.W. Nichols, S.R. Wolman, K.A. Soper, P.D. Stolley, P. Archer, Chromosome aberrations in individuals occupationally exposed to ethylene oxide, and in a large control population, Mutation Res. 170 (1986) 55-74.
11. [11] D. Anderson, P.C. Jenkinson, R.S. Dewdney, Anne J. Francis, P. Godbert, K.R. Buterworth, Chromosome aberrations, mitogen-induced blastogenesis and proliferate rate index in peripheral lymphocytes from 106 control individuals of the UK population, Mutation Res. 204 (1988) 407-420.
12. [12] M.A. Bender, R.J. Preston, R.C. Leonard, B.E. Pyatt, P.C. Gooch, M.D. Shelby, Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample, Mutation Res. 204 (1988) 421-433.
13. [13] B. Sinues, M. Izquierdo, J. Perez Viguera, Chromosome aberrations and urinary thioethers in smokers, Mutation Res. 240 (1990) 289-293.
14. [14] V. Kasuba, K. Sentija, V. Garaj-Vrhovac, A. Fucic, Chromosome aberrations in peripheral blood lymphocytes from control individuals, Mutation Res. 346 (1995) 187-193.
15. [15] C.P. Milillo, F. Gemignani, I. Sbrana, L. Carrozzi, G. Viegi, R. Barale, Chromosome aberrations in humans in relation to site of residence, Mutation Res. 360 (1996) 173-179.
16. [16] E.J. Tawn, The frequency of chromosome aberrations in a control population, Mutation Res. 182 (1987) 303-308.
17. [17] M.J. Ramsey, D.H. Moore II, J.F. Briner, D.A. Lee, L.A. Olsen, J.R. Senft, J.D. Tucker, The effects of age and lifestyle on the accumulation of cytogenetic damage as measured by chromosome painting, Mutation Res. 338 (1995) 95-106.
18. [18] N. Conforti-Froes, R. El-Zein, S.Z. Abdel-Rahman, J.B. Zwischenberger, W.W. Au, Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers, Mutation Res. 379 (1997) 53-59.
19. [19] J. Maki-Paakkanen, M. Sorsa, H. Vainio, Sister chromatid exchanges and chromosome aberrations in rubber workers, Carcinogenesis 4 (1984) 189-200.
20. [20] A.K. Sinha, V.A. Linscombe, B.B. Gollapudi, G.C. Jersey, R.E. Flake, Cytogenetic variability of lymphocytes from phenotypically normal men: influence of age, smoking season, and sample storage, J. Toxic Environ. Health 17 (1986) 327-345.
21. [21] P. Bigatti, L. Lamberti, G. Ardito, F. Armellino, Cytogenetic monitoring of hospital workers exposed to low-level ionizing radiation, Mutation Res. 204 (1988) 343-347.
22. [22] M. Johnansson, C. Orndal, No difference between smoking lung cancer patients and smoking controls in the frequency of spontaneous and mitomycin C induced chromosome aberrations in lymphocytes, Hereditas 111 (1989) 61-63.
23. [23] L.G. Littlefield, E.E. Joiner, Analysis of chromosome aberrations in lymphocytes of long-term heavy smokers, Mutation Res. 170 (1986) 145-150.
24. [24] E.J. Tawn, C.L. Cartmell, The effect of smoking on the frequencies of asymmetrical and symmetrical chromosome exchanges in human lymphocytes, Mutation Res. 224 (1989) 151-156.
25. [25] B.B. Ganguly, Cell division, chromosome damage and micronucleus formation in peripheral lymphocytes of healthy donors: related to donors age, Mutation Res. 295 (1993) 135-148.
26. [26] P.C.M. van Diemaen, D. Maasdam, S. Vermeulen, F. Darroudi, A.T. Natarajan, Influence of smoking habits on the frequencies of structural aberrations in human peripheral blood lymphocytes using the fluorescence in situ hybridization (FISH) technique, Mutagenesis 10 (6) (1995) 487-495.
27. [27] W.W. Au, D.M. Walker, J.B. Ward Jr., E. Whorton, M.S. Legator, V. Singh, Factors contributing to chromosome damage in lymphocytes of cigarette smokers, Mutation Res. 260 (1991) 137-144.
28. [28] C.J. Piyathilake, M. Macaluso, R.J. Hine, D.W. Vinster, E.W. Richards, C.L. Krumdieck, Cigarette smoking, intracellular vitamin deficiency, and occurrence of micronuclei in epithelial cells of the buccal mucosa, Cancer Epidemiol. Biomarkers Prev. 4 (1995) 751-758, (Suppl. 7).
29. [29] K. Radack, V. Martin, R. Wones, R. Buncher, S. Piney, K. Mandell, Intercorrelations and sources of variability in three mutagenicity assays: a population-based study, Mutation Res. 350 (1996) 295-306.
30. [30] M.L. Larramendy, S. Knuutila, Increased frequency of micronuclei in B and T8 lymphocytes from smokers, Mutation Res. 259 (2) (1991) 189-195.
31. [31] T.J. Cheng, D.C. Christiani, X. Xu, J.C. Wain, J.K. Wiencke, K.T. Kelsey, Increases micronucleus frequency in lymphocytes from smokers with lung cancer, Mutation Res. 349 (1) (1996) 43-50.
32. [32] D.R. Robinson, K. Goodall, R.J. Albertini, J.P. O'Neill, B. Finett, M. Sala-Trepat, A.D. Tates, E. Moustacchi, D. Beare, M.H.L. Green, J. Cole, An analysis of in vivo HPRT mutant frequency in circulating T-lymphocytes in the normal human populations: a comparison of four data sets, Mutation Res. 313 (1994) 227-247.
33. [33] M.H.L. Green, J.P. O'Neill, J. Cole, Suggestions concerning the relationship between mutant frequency and mutation rate at the HPRT locus in human peripheral T-lymphocytes, Mutation Res. 334 (1995) 323-339.
34. [34] A.D. Tates, F.J. van Dam, H. van Mossel, H. Schoemaker, J.C.P. Thijssen, V.M. Woldring, A.M. Zwinderman, A.T. Natarajan, Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes for five control populations, Mutation Res. 253 (1991) 199-213.
35. [35] R.F. Branda, J.P. O'Neill, D. Jacobson-Kram, R.J. Albertini, Factors influencing mutation at the hprt locus I T-lymphocytes: studies in normal women and women with benign and malignant breast masses, Environ. Mol. Mutation 1 (1992) 274-281.
36. [36] R.F. Branda, L.M. Sullivan, J.P. O'Neill, M.T. Falta, J.A. Nicklas, B. Hirsch, P.M. Vacek, R.J. Albertini, Measurement of HPRT mutant frequencies in T-lymphocytes for healthy human populations, Mutation Res. (1993) 271-279.
37. [37] I.M. Jones, D.H. Moore, C.B. Thomas, C.L. Thompson, C.L. Strout, K. Burkhart-Schultz, Factors affecting hprt mutant frequency in T-lymphocytes of smokers and non-smokers, Cancer 2 (1993) 249-260.
38. [38] I.M. Jones, C.B. Thomas, B. Tucker, B. Tucker, C.L. Thompson, P. Pleshanov, I. Vorobtsova, D.H. Moore II, Impact of age and environmental on somatic mutation at the hprt gene of T-lymphocytes in humans, Mutation Res. 338 (1995) 129-139.
39. [39] S.J. Duthie, M. Ross, A.R. Collins, The influence of smoking and diet on the hypoxanthine phosphoribosyltransferase (hprt) mutant frequency in circulating T-lymphocytes from a normal human population, Mutation Res. 331 (1995) 55-64.
40. [40] L. Henderson, H. Cole, J. Cole, S.E. James, M. Green, Detection of somatic mutations in man: evaluation of the microtitre cloning assay for T-lymphocytes, Mutagenesis 1 (3) (1986) 195-200.
41. [41] J. Cole, M.H.L. Green, S.E. James, L. Henderson, H. Cole, A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes, Mutation Res. 204 (1988) 493-507.
42. [42] R.J. Albertini, L.M. Sullivan, J.K. Berman, C.J. Greene, J.A. Stewart, J.M. Silveira, J.P. O'Neill, Mutagenicity monitoring in humans by autoradiographic assay for mutant T-lymphocytes, Mutation Res. 204 (1988) 481-492.
43. [43] M.J. McGinniss, M.T. Falta, L.M. Sullivan, R.J. Albertini, In vivo hprt mutant frequencies in T-cells of normal human newborns, Mutation Res. 240 (1990) 117-132.
44. [44] M. Sala-Trepat, J. Cole, M.H.L. Green, O. Rigaud, J.R. Vilcoq, E. Moustacchi, Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients: III. Measurement of mutant frequency to 6-thioguanine resistance, Mutagenesis 5 (6) (1990) 593-598.
45. [45] M. Caggana, H.L. Liber, P.M. Mauch, C.N. Coleman, K.T. Kelsey, In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients, Environ. Mol. Mutagen. 18 (1991) 6-13.
46. [46] M.J. Davies, D.P. Lovell, D. Anderson, Thioguanine-resistant mutant frequency in T-lymphocytes from a healthy human population, Mutation Res. 265 (1992) 165-171.
47. [47] E. Huttner, B. Holzapfel, S. Kropf, Frequency of HPRT mutant lymphocytes in a human control population as determined by the T-cell cloning procedure, Mutation Res. 348 (1995) 83-91.
48. [48] E. Huttner, B. Holzapfel, HPRT mutant frequencies and detection of large deletions by multiple PCR in human lymphocytes of vinyl chloride exposed and non-exposed populations, Toxicol. Lett. 88 (1996) 175-183.
49. [49] M.M. Ammenheuser, J.B. Ward Jr., J.M. Killian, M.S. Legator, Elevated frequencies of 6-thioguanine resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study, Mutation Res. 204 (1988) 509-528.
50. [50] P. Ostrosky-Wegman, P.R. Montero, A. Palao, C. Cortinas De Nava, F. Hurtado, R.J. Albertini, 6-thioguanine-resistant T-lymphocyte autoradiographic assay, determination of variation frequencies in individuals suspected of radiation exposure, Mutation Res. 232 (1990) 49-56.
51. [51] E. Huttner, U. Mergner, R. Brawn, J. Schoneich, Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed in cyclophosphamide production, Mutation Res. 243 (1990) 101-107.
52. [52] M.M. Ammenheuser, A.B. Berenson, N.J. Stiglich, E.B. Whorton, J.B. Ward, elevated frequencies of HPRT mutant lymphocytes in cigarette-smoking mothers and their newborns, Mutation Res. 304 (1994) 285-294.
53. [53] M.M. Ammenheuser, D.A. Hastings, E.B. Whorton Jr., J.B. Ward Jr., Frequencies of HPRT mutant lymphocytes in smokers, non-smokers, and former smokers, Environ. Mol. Mutagen. 30 (1997) 131-138.
54. [54] D.S. Rupa, Hasegawa, D.A. Eastmond, Detection of chromosomal breakage in the 1cen-1q12 region of interphase human lymphocytes using multicolor fluorescence in situ hybridization with tandem DNA probes, Cancer Res. 55 (1995) 640-645.
55. [55] J. Cole, T.R. Skopek, Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo, Mutation Res. 304 (1994) 33-105.
56. [56] P.P. Gengerich, D.H. Kim, M. Iwasaki, Role of human cytochrome P-450 IIEI in the oxidation of many low molecular weight cancer suspects, Chem. Res. Toxicol. 4 (1991) 168-179.
57. [57] P.G. Shields, Pharmacogenetics: detecting sensitive populations, Environ. Health Perspect. 102 (11) (1994) 81-87.
58. [58] A.K. Daly, S. Cholerton, G. Wendy, J.R. Idle, Metabolic polymorphism, Pharmacol. Ther. 57 (1993) 129-160.
59. [59] W.A. Anwar, S.Z. Abdel-Rahman, R.A. El-Zein, H.M. Mostafa, W.W. Au, Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients, Carcinogenesis 17 (1996) 1923-1929.
60. [60] R. El-Zein, J.B. Zwischenberger, S.Z. Abdel-Rahman, A.B. Sankar, W.W. Au, Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma, Cancer Lett. 112 (1997) 71-78.
61. [61] R. El-Zein, N. Conforti-Froes, W.W. Au, Interactions between genetic predisposition and environmental toxicants for development of lung cancer, Environ. Mol. Mutagen. 30 (1997) 196-204.
62. [62] R. El-Zein, J.B. Zwischenberger, T.G. Wood, S.Z. Abdel-Rahman, C. Brekelbaum, W.W. Au, Combined genetic polymorphism and risk for development of lung cancer, Mutation Res., 1998, in press.
63. [63] S.Z. Abdel-Rahman, W.A. Anwar, H.M. Mostafa, M.A. Abdel-Aal, M. Ghoneim, W.W. Au, The CYP2D6 extensive metabolizer genotype increases the risk for bladder cancer, Cancer Lett. 119 (1997) 115-122.
64. [64] S.Z. Abdel-Rahman, W.A. Anwar, S. Mostafa, W.W. Au, GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer, Cancer Detect. Prev., 1998, in press.
65. [65] S. Abdel-Rahman, R. El-Zein, J.B. Zwischenberger, W.W. Au, Association of the NAT1 * 10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers, Mutation Res. 398 (1998) 43-54.
66. [66] M. Ichiba, L. Hagmar, A. Rannug, B. Hogstedt, A.K. Alexandrie, U. Carstensen, K. Hemminki, Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps, Carcinogenesis 15 (7) (1994) 1347-1352.
67. [67] R.A. Grinberg-Funes, V.N. Singh, F.P. Perera, D.A. Bell, T.L. Young, C. Dickey, L.W. Wang, R.M. Santella, Polycyclic aromatic hydrocarbon - DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype, Carcinogenesis 15 (11) (1994) 2449-2454.
68. [68] J. Topinka, B. Binkova, G. Mrackova, Z. Stavoka, V. Peterka, I. Benes, J. Dejmek, J. Lenicek, T. Pilcik, R.J. Sram, Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population, Environ. Mol. Mutagen. 30 (1997) 184-195.
69. [69] R. Scarpato, A. Hirvonen, L. Migliore, G. Falck, H. Norppa, Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers, Mutation Res. 389 (1997) 227-235.
70. [70] T.J. Cheng, D.C. Christiani, X. Xu, J.C. Wain, J.K. Wienckl, K.T. Kelsey, Glutathaione S-transferase μ genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes, Cancer 4 (1995) 535-542.
71. [71] C.H. Sierra-Torre, N. Cajas-Salazar, B.K. Shipp, M. Serrana, W.W. Au, Modification of genotoxicity in an exposed population by inheritance of polymorphic metabolizing genes, Environ. Mol. Mutagen. 31, suppl. 2, 62, 1998.
72. [72] J.C. Barrett, H. Vainio, D. Peakall, B.D. Goldstein, 12th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: Susceptibility to environmental hazards, Environ. Health Perspect. 105 (S 4) (1997) 699-737.
73. [73] H. Raunio, K. Husgafuel-Persianien, S. Anttila, E. Heitanen, A. Hirvonen, O. Pelkonen, Diagnosis of polymorphism in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review, Gene 159 (1995) 113-121.
74. [74] P. Board, M. Coggan, P. Johnston, V. Ross, T. Suzuki, Genetic heterogeneity of the human glutathione S-transferases: a complex of gene families, Pharmacol. Ther. 48 (1990) 357-369.
75. [75] D.A. Bell, J.A. Taylor, M.A. Butler, E.A. Stephens, J. Wiest, L.H. Brubaker, F.F. Kadlubar, G.W. Lucia, Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans, Carcinogenesis 14 (1993) 1689-1692.
76. [76] R. Humbert, D.A. Adler, C.M. Disteche, C. Hassett, C.J. Omiecinski, C.E. Furlong, The molecular basis of the human serum paraoxonase activity polymorphism, Nat. Genet. 3 (1993) 73-76.
77. [77] B.S. Hulka, T.C. Wilcosky, J.D. Griffith, Biological Markers in Epidemiology, Oxford University Press, New York, 10090, 1990.
78. [78] R.J. Albertini, J.A. Nicklas, J.P. O'Neill, Future research directions for evaluation human genetic and cancer risk for environmental exposures, Environ. Health Perspect. 104 (3) (1996) 503-510.
79. [79] W.W. Au, G.S. Wilkinson, S.K. Tyring, M.S. Legator, R. El Zein, L. Hallberg, M.Y. Heo, Monitoring populations for DNA repair deficiency and for cancer susceptibility, Environ. Health Perspect. 104 (3) (1996) 579-584.
80. [80] L. Hagmar, A. Brogger, I.L. Hansteen, S. Heim, B. Hogstedt, L. Knudsen, B. Lambert, K. Linnainmaa, F. Mitelman, I. Nordenson, C. Reuterwall, S. Salomaa, S. Skerfing, M. Sorsa, Cancer risk in humans predicted by increased levels of chromosome aberrations in lymphocytes: nordic study group on the health risk of chromosome damage, Cancer Res. 54 (1994) 2919-2922.
81. [81] L. Hagmar, S. Bonassi, U. Stromberg, A. Brogger, L. Knudsen, H. Norrpa, C. Reuterwall, Chromosomal aberrations in lymphocytes predict human cancer - a report from the European study group on cytogenetic biomarkers and health (ESCH), Cancer Res., 1998, in press.
82. [82] S. Bonassi, A. Abbondandolo, L. Canurri, L. Dal Pra, M. de Ferrari, F. Degrassi, A. Forni, L. Lamberti, C. Lando, P. Padovani, I. Sbrana, D. Vecchio, R. Puntoni, Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans?, Cancer Genet. Cytogenet. 79 (1995) 133-135.
83. [83] R.J. Albertini, J.A. Nicklas, J.C. Fuscoe, T.R. Skopek, R.F. Branda, J.P. O'Neill, In vivo mutations in human blood cells: biomarkers for molecular epidemiology, Environ. Health Perspect. 99 (1993) 135-141.
84. [84] Y. Liu, G. Cortopassi, H. Steingrimsdottir, A.P.W. Waugh, D.M. Beare, M.H.L. Green, D.R. Robinson, J. Cole, Correlated mutagenesis of bcl2 and hprt loci in blood lymphocytes, Environ. Mol. Mutagen. 29 (1997) 36-45.
85. [85] H. Norppa, Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes, Environ. Health Perspect. 105 (4) (1997) 829-835.